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Abstract
In the retina, the L-type voltage-gated calcium channels (L-VGCCs) are responsible for neurotransmitter release from
photoreceptors and are under circadian regulation. Both the current densities and protein expression of L-VGCCs are
significantly higher at night than during the day. However, the underlying mechanisms of circadian regulation of L-
VGCCs in the retina are not completely understood. In this study, we demonstrated that the mechanistic/mammalian
target of rapamycin complex (mTORC) signaling pathway participated in the circadian phase-dependent modulation
of L-VGCCs. The activities of the mTOR cascade, from mTORC1 to its downstream targets, displayed circadian
oscillations throughout the course of a day. Disruption of mTORC1 signaling dampened the L-VGCC current
densities, as well as the protein expression of L-VGCCs at night. The decrease of L-VGCCs at night by mTORC1
inhibition was in part due to a reduction of L-VGCCα1 subunit translocation from the cytosol to the plasma
membrane. Finally, we showed that mTORC1 was downstream of the phosphatidylionositol 3 kinase-protein kinase B
(PI3K-AKT) signaling pathway. Taken together, mTORC1 signaling played a role in the circadian regulation of L-
VGCCs, in part through regulation of ion channel trafficking and translocation, which brings to light a new functional
role for mTORC1: the modulation of ion channel activities.
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Introduction
The mechanistic/mammalian target of rapamycin (mTOR)
signaling pathway governs diverse cellular physiological
functions including cell growth, cell survival, energy balance,
and metabolism in response to environmental signals such as
nutrients and stress [1–6]. mTOR, a conserved serine (ser) /
threonine (thr) protein kinase, is composed of two distinct
complexes, namely mTOR complex 1 (mTORC1) and
mTORC2. mTORC1 regulates cell growth by increasing protein
synthesis through phosphorylation of downstream targets, p70
ribosomal S6 kinase (p70S6K) and eukaryotic translation
initiation factor 4E-binding protein 1(4EBP1) [7–11], while
mTORC2 regulates cell survival and cytoskeletal organization
[12–15]. In the retina, mTOR signaling is important for cell
survival and axon regeneration. Stimulation of mTOR signaling
by insulin prolongs the survival of retinal neurons [16,17], and
depletion of the negative regulators of mTOR promotes axon
regeneration in retinal ganglion cells after optic nerve injury
[18,19]. Under hyperglycemic conditions, the suppression of
mTOR activity in diabetic retinas causes apoptosis [20].
Therefore, the mTOR signaling pathway is essential for
maintaining retinal metabolic homeostasis and health.
While mTOR is essential in metabolism and cell survival, it is
also involved in the circadian regulation of both vertebrates and
invertebrates [21–23]. The circadian clocks regulate
metabolism, physiological processes, and behaviors across the
course of a day, and these internal time-keeping mechanisms
allow organisms to anticipate and adapt to daily external
environmental changes such as cycling ambient illumination
and temperature fluctuations [24,25]. The canonical core
mechanism underlying the circadian oscillations is composed
of a specific set of “clock genes” and their protein products,
which form self-regulated transcriptional-translational feedback
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loops with a period close to 24 hours [24,25]. However, other
post-translational mechanisms such as phosphorylation,
methylation, and ubiquitination, as well as various cellular
signaling pathways are also involved in the circadian
mechanism or the circadian regulation of downstream targets
[26]. mTOR signaling is involved with the core circadian
oscillator components and affects the rhythmicity. Disruption of
mTOR signaling alters the light-induced expression of the
Period gene, a core oscillator component [22], as well as light-
induced phase shifting in animal activity rhythm [22], while
activation of mTOR signaling impacts the nuclear accumulation
of the clock protein TIMELESS and lengthens the circadian
period in Drosophila [21]. Hence, mTOR signaling may
participate in the core circadian mechanism.
In the vertebrate retina, many physiological aspects are
under circadian control, since the visual system has to adapt to
large changes in ambient illumination throughout the day
[27,28]. In particular, the circadian oscillators in retinal
photoreceptors regulate daily changes in retinomotor
movement [29,30], outer segment shedding and renewal [31],
gene and protein expression [32–35]; morphological changes
at synaptic ribbons [36], as well as ion channel activities
[37,38]. We previously showed a circadian regulation of L-type
voltage-gated calcium channels (L-VGCCs) in cone
photoreceptors [38]. The L-VGCCs are essential for
neurotransmitter release from photoreceptors and other retinal
neurons [39]. We further demonstrated that both Ras-mitogen-
activated protein kinase (MAPK) and Ras-phosphatidylionositol
3 kinase-protein kinase B (PI3K-AKT) signaling pathways are
part of the circadian output pathway mediating L-VGCC
trafficking and insertion in a circadian phase-dependent
manner [38,40]. Since mTOR is involved in the circadian
mechanism, we investigated whether it also participates as part
of the circadian output pathway to regulate L-VGCCs in cone
photoreceptors. We combined biochemical, morphological, and
electrophysiological analyses to examine the potential
circadian phase-dependent modulation of L-VGCCs by mTOR
and its potential interaction with other signaling pathways.
Experimental Procedure
Cell cultures and circadian entrainment
Fertilized eggs (Gallus gallus) were obtained from the Poultry
Science Department, Texas A&M University (College Station,
TX, USA). Chicken retinas were dissociated at embryonic day
12 (E12) and cultured for 6 days as described previously
[38,40]. Cultures were prepared in the presence of 20 ng/ml
ciliary neurotrophic factor (CNTF; R&D Systems, Minneapolis,
MN, USA), which yields cultures highly enriched with cone
photoreceptors [41–43] and 10% heat-inactivated horse serum.
Cell culture incubators (maintained at 39°C and 5% CO2) were
equipped with lights and timers, which allowed for the
entrainment of retinal circadian oscillators to 12h: 12h light-dark
(LD) cycles in vitro. Zeitgeber time zero (ZT 0) was designated
as the time when the lights turned on and ZT 12 was the time
when the lights went off. For in ovo entrainment, intact eggs
were exposed to LD 12h: 12h at E10-E11 for 7 days. Retina
cells were then dissociated, cultured, kept in constant darkness
(DD), and used for biochemical and molecular biological
assays on the second day of DD. In some experiments, after in
ovo LD entrainment for 6 days, eggs were kept in DD. On the
second day of DD, retinas were collected at different circadian
time (CT) points throughout a day for biochemical assays
[38,40]. The reason for using chick embryos from E12+6 for in
vitro entrainment or E18 for in ovo entrainment is that more
than 90% of the retina photoreceptors express functionally
mature VGCC currents by E18 [44].
Immunoblot analysis
Samples were collected and prepared as described
previously [45]. Briefly, intact retinas were homogenized in Tris
lysis buffer including (in mM): 50 Tris,1 EGTA, 150 NaCl, 1%
Triton X-100, 1% β-mercaptoethanol, 50 NaF, 1 Na 3VO4; pH
7.5. Samples were separated on 10% sodium dodecyl sulfate–
polyacrylamide gels by electrophoresis and transferred to
nitrocellulose membranes. The primary antibodies used in this
study were: anti-di-phospho-ERK (pERK; Sigma, St. Louis,
MO, USA), anti- ERK (total ERK, used for loading control;
Santa Cruz Biochemicals, Santa Cruz, CA, USA), anti-
VGCCα1D (Alomone, Jerusalem, Israel), anti-phospho-
mTORC1 (ser2448; Cell Signaling Technology, Danvers, MA,
USA), anti-phospho-mTORC1 (ser2481; Cell Signaling
Technology), anti-mTORC (total mTORC, Cell Signaling
Technology), anti-phospho-S6 (ser240/244; Cell Signaling
Technology), anti-S6 (Cell Signaling Technology), anti-
phospho-p70S6K (thr389; Cell Signaling Technology), and anti-
p70S6K (Cell Signaling Technology). Blots were visualized
using appropriate secondary antibodies conjugated to
horseradish peroxidase (Cell Signaling Technology) and an
enhanced chemiluminescence (ECL) detection system (Pierce,
Rockford, IL, USA). Relative protein expressions for all proteins
involved in this study are reported as a ratio to total ERK since
total ERK remains constant throughout the day. Band
intensities were quantified by densitometry using Scion Image
(NIH, Bethesda, MD, USA). All measurements were repeated
at least 3 times.
Electrophysiology
Whole cell patch-clamp configuration of L-VGCC current
recordings were carried out using mechanically ruptured
patches. For retinal photoreceptors, the external solution was
(in mM): 110 NaCl, 10 BaCl2, 0.4 MgCl2, 5.3 KCl, 20 TEA-Cl,
10 HEPES, and 5.6 glucose, pH 7.35 with NaOH. The pipette
solution was (in mM): 135 Cs acetate, 10 CsCl, 1 NaCl, 2
MgCl2, 0.1 CaCl2, 1.1 EGTA, and 10 HEPES, pH 7.3 adjusted
with CsOH. Recordings were made only from cells with
elongated cell bodies with one or more prominent oil droplets
(hallmark of avian cone photoreceptors) [33,37,44]. Currents
were recorded at room temperature (RT, 23°C) using an
Axopatch 200B (Axon Instruments/Molecular Devices, Union
City, CA, USA) or A-M 2400 amplifier (A-M Systems Inc.,
Carlsborg, WA, USA). Signals were low-pass filtered at 2 kHz
and digitized at 5 kHz with Digidata 1440A interface and
pCLAMP 10.0 software (Molecular Devices). Electrode
capacitance was compensated after gigaohm (GΩ) seals were
formed. Cells were held at -65mV, and ramp voltage
mTORC1 and L-Type Voltage-Gated Calcium Channel
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commands from -80 to +60 mV in 500 ms were used to evoke
Ba2+ currents. Current–voltage (I–V) relations were also elicited
from a holding potential of -65 mV in 200 ms steps (5 s
between steps) to test potentials over a range of -80 to +60 mV
in 10 mV increments. The maximal currents were obtained
when the steps depolarized to 0 ~ +10 mV. The membrane
capacitance, series resistance, and input resistance of the
recorded photoreceptors were measured by applying a 5 mV
(100 ms) depolarizing voltage step from a holding potential of
-65 mV. Cells with an input resistance smaller than 1 GΩ were
discarded. The membrane capacitance reading was used as
the value for whole cell capacitance. The current densities
(pA/pF) were obtained by dividing current amplitudes by
membrane capacitances. Rapamycin and PP242 were
obtained from A.G. Scientific (San Diego, CA, USA) and
Chemdea (Ridgewood, NJ, USA), respectively. Both rapamycin
and PP242 were dissolved in DMSO (the final concentration of
DMSO vehicle was 0.1%).
Calcineurin activity assay
Retina samples were lysed in a phosphatase lysis buffer
including (in mM): 50 Tris, pH 7.5, 1 EGTA, 150 NaCl, 1%
Triton X-100, and 1% β-mercaptoethanol, and calcineurin
activities were assayed using a commercially available ser/thr
phosphatase assay kit (Promega, Madison, WI, USA). This kit
can distinguish between tyrosine (tyr) and ser/thr phosphatases
by using a synthetic polypeptide, RRA(pT) VA, that is
compatible with ser/thr phosphatases but is structurally
incompatible for tyr phosphatases. To differentiate between
PP2A, 2B, and 2C, the reaction buffer is made to favor one
over the others since this class of enzyme has a diverse range
of optimum conditions. For calcineurin (PP2B), the reaction
buffer contained 250 mM imidazole (pH 7.2), 1 mM EGTA, 50
mM MgCl2, 5 mM NiCl2, 250 µg/ml calmodulin, and 0.1% β-
mercaptoethanol as described in the manufacturer’s protocol.
Free cytoplasmic phosphate was first removed from the
samples then dephosphorylation of the kit’s calcineurin
substrate proceeded for 30 min at RT. This system determines
the amount of free phosphate generated in a reaction by
measuring the absorbance (600 nm) of a molybdate/ malachite
green/ phosphate complex.
Immunocytochemistry
Dissociated retinas were cultured on coverslips and
entrained under LD cycle for four days. Cell were then fixed at
CT4 or CT16 with Zamboni fixative for 30 min at RT, washed in
phosphate buffer (0.1M PB, pH7.4), and permeabilized in 1%
Triton-X PB for 10min. Samples were blocked in 10% goat
serum in 0.1% Triton-X/PB for 2 hr at RT, then incubated with
VGCCα1D primary antibody (1:100) overnight. The cells were
washed with 0.1% Triton-X/PB and incubated with fluorescent
conjugated secondary antibody (Alexa 488nm goat anti-rabbit;
Molecular Probes, Carlsbad, CA, USA) for 2 hr in the dark.
Coverslips were then re-washed and mounted with ProLong®
Gold antifade reagents with 4',6-diamidino-2-phenylindole
(DAPI; Invitrogen, Eugene, OR, USA) on a glass slide and
stored at 4°C for later observation on a Zeiss microscope
(Thornwood, NY, USA) with epi-fluorescence to determine the
localization of VGCCα1D and the nucleus (with DAPI). Green
or blue fluorescent images were taken under identical settings
including exposure time and magnification. The fluorescence
intensity was measured using Adobe Photoshop 12 software
(Adobe Systems, San Jose, CA, USA) as described previously
[38]. The fluorescence intensity analyses were carried out
blindly. The experiment was repeated at least four times.
Statistical analysis
All data are presented as mean ± SEM (standard error of
mean). One-way analysis of variance (ANOVA) followed by
Tukey’s post hoc test for unbalanced n was used for statistical
analyses. Throughout, * p<0.05 was regarded as significant.
Any defined rhythmic expression had to exhibit at least a 1.5
fold change in rhythmic amplitude [46].
Results
mTORC1 signaling is under circadian control
mTORC1 signaling participates in light-induced phase-shifts
in mammals, as well as in the changes of circadian period in
Drosophila [21–23]. We first investigated whether mTOR
signaling was under circadian control in the avian retina, since
the phosphorylation states of mTORC1 signaling display
circadian rhythms in the suprachiasmatic nucleus (SCN) [47].
Chicken retinal samples were collected at six different circadian
time (CT) points on the second day of DD after LD entrainment
and used for Western blotting analysis. Since the total amount
of ERK (total ERK) is constant throughout the day [37], we
used total ERK as the loading control. We found that the
phosphorylation status of mTORC1 was under circadian
regulation, and it was a site-specific regulation. The
phosphorylation at ser 2448 of mTORC1 (pTORC1ser2448), the
site that monitors mTORC1 activity [48,49], peaked at CT 12
(Figure 1A), but phosphorylation at ser2481 (pTORC1ser2481) on
the regulatory domain, as well as total mTORC1, remained
constant (Figure 1B). Downstream of mTORC1, the
phosphorylation states of p70S6 kinase (pp70S6K) and S6
ribosomal kinase (pS6) were also rhythmic with peaks at CT 12
(Figure 1C, 1D), while total p70S6K and S6 protein remained
constant. Hence, the activation state of mTORC1 signaling was
under circadian regulation in the retina.
mTORC1 is involved in the circadian regulation of L-
VGCC currents
In the retina, the L-VGCCs are essential in neurotransmitter
release from photoreceptors and other retinal neurons [39], and
these channels are under circadian control in cone
photoreceptors [38] and bipolar cells [50]. The maximal
currents of L-VGCCs elicited at 0 mV are significantly larger at
night than during the day (Figure 2A, 2B [38]). To investigate
whether mTORC1 was involved in the circadian regulation of L-
VGCCs, we applied rapamycin to inhibit mTORC1 in the
following experiments. Rapamycin forms a complex with
tacrolimus (FK506) binding protein 12 (FKBP12), an
intracellular receptor protein, to inhibit mTORC1 activity
(mTORC1 is more sensitive to rapamycin inhibition than
mTORC1 and L-Type Voltage-Gated Calcium Channel
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Figure 1.  mTORC1 signaling is under circadian control.  On the second day of DD after circadian entrainment to 12: 12 hr LD
cycles for 7 days in ovo, intact retinas were collected at 6 different circadian time points (CT 0, 4, 8, 12, 16, and 20) for
immunoblotting analysis. (A) Phosphorylation of mTORC1 at ser2448 (pTORC1ser2448) showed a circadian rhythm with its peak at CT
12. (B) The total amount of mTORC1 (total TORC1) and mTORC1 phosphorylation at ser2481 (pTORC1ser2481) did not display
circadian rhythmicity. (C) Phosphorylation of the downstream target of mTORC1, p70-S6 kinase 1(pp70S6K), displayed a circadian
rhythm with a peak at CT 12 (upper panel), while total p70S6K (lower panel) remained constant. (D) Phosphorylation of S6
ribosomal protein (pS6), the downstream target of p70S6 kinase, exhibited a circadian rhythm with a peak at CT 12 (upper panel),
with total S6 protein (lower panel) constant throughout the day. * indicates a statistical significance at CT 12 compared to CT 0,
CT4, or CT8. *p<0.05.
doi: 10.1371/journal.pone.0073315.g001
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mTORC2 [51]). After 2 hr treatment of rapamycin (1 µM), the L-
VGCC current densities in cone photoreceptors were
significantly dampened at night (ZT 16-20; Figure 2C, 2D),
while there was no effect on currents recorded during the
daytime (ZT 4-8; Figure 2C, 2D). Similar results were observed
at a higher rapamycin concentration (10 µM; Figure 2E, 2F). To
verify our observations were truly caused by the inhibition of
mTOR, we applied PP242, another mTOR inhibitor not related
to rapamycin structurally or mechanistically. PP242 inhibits
both mTORC1 and mTORC2 by competing for ATP binding
sites [52]. Treatment with PP242 (400 nM; 2 hr) significantly
decreased the circadian rhythm of L-VGCC current densities at
night (Figure 3A, 3D, 3E). Similar results were obtained at
lower concentrations (100 nM) where PP242 inhibits mTORC1
more specifically than mTORC2 [52] (Figure 3A, 3B, 3C).
Therefore, mTOR signaling caused a circadian phase-
dependent modulation of L-VGCCs in chick cone
photoreceptors, in which inhibition of mTOR significantly
reduced L-VGCC currents at night.
We previously also demonstrated that calcineurin, a ser/thr
phosphatase, regulates the L-VGCCs in a circadian phase-
dependent manner, where inhibition of calcineurin dampens L-
VGCC currents at night [45]. Rapamycin and FK506 are
structurally related immunosuppressants that inhibit the
lymphocyte-activation pathway through binding to FKBP12
[53–56]. While the rapamycin-FKBP12 complex inhibits
mTORC1 signaling, the FK506-FKBP12 complex targets
calcineurin [57]. Because of the structural similarities between
rapamycin and FK-506 [58–60], we further verified that the
action of rapamycin was not though interference of calcineurin
activity at the concentrations used in this study. We examined
calcineurin activity after cultured retinal cells were treated with
rapamycin (10 µM or 1 µM), PP242 (400 nM), or DMSO (0.1%,
control) for 2 hrs. At these concentrations, rapamycin and
PP242 did not inhibit calcineurin activity (Figure 3F), consistent
with other reports [61,62], while FK-506 clearly inhibits
calcineurin activity as we and others have previously shown
[45,61]. Hence, we used 1 µM rapamycin and 400 nM PP242
to inhibit mTORC signaling for the following experiments.
mTORC1 is involved in the circadian regulation of L-
VGCCα1D protein expression and channel trafficking
Since mTORC1 was involved in the circadian phase-
dependent modulation of L-VGCC currents in cone
photoreceptors, we next examined whether mTORC1 affected
the protein expression of L-VGCCα1D and its trafficking from
the cytosol to the plasma membrane. In the mammalian retina,
the distribution of L-VGCCα1D in photoreceptors is wide-
ranging from the inner segment layer, outer nucleus layer, and
outer plexiform layer [63]. In avian cone photoreceptors, L-
VGCCα1D is concentrated in the inner segment (including
soma, Fig. 4 [38]). There was a significantly higher L-
VGCCα1D fluorescence intensity in cone photoreceptors when
cultures were fixed at CT 16 compared to CT 4 (Fig. 4A, top
panel, Fig. 4B). Treatment with rapamycin for 2 hr significantly
decreased the fluorescence intensity of L-VGCCα1D in
photoreceptors fixed at CT 16 (Fig. 4A, lower panel, Fig. 4B).
Using Western blot analysis, we found that retinal cultures
treated with rapamycin or PP242 for 2 hr decreased the protein
expression of L-VGCCα1D when cultures were harvested at
night (CT 16; Figure 5A). We further used biotinylation assays
to differentiate plasma membrane-bound versus cytosolic L-
VGCCα1D and found that inhibition of mTORC1 significantly
decreased the plasma membrane-bound L-VGCCα1D when
cells were harvested at night (CT 16; Figure 5B1, 5B2). These
results indicated that mTORC1 participated in the circadian
regulation of protein expression and translocation of L-
VGCCα1D. Since physiologically functional ion channels have
to be transported and inserted into the plasma membrane first,
these results echo the earlier data that mTORC1 is involved in
the circadian regulation of L-VGCC currents (Figures 2, 3).
mTORC1 is a downstream target of the PI3K-AKT
pathway
We previously showed that the circadian regulation of L-
VGCCs is in part through the regulation of channel trafficking
[40]. The MAPK-ERK and PI3K-AKT signaling pathways are
involved in ion channel translocation in neurons or
cardiomyocytes [40,64,65], and both are downstream of Ras
and parallel to each other in the circadian regulation of L-
VGCC trafficking [40]. The phosphorylation/activation states of
ERK and AKT are also under circadian control in the retina
[37,38,40]. More specifically, the di-phosphorylation of ERK
(pERK) and phosphorylation of AKT at thr308 (pAKTthr308) are
significantly higher at night than during the day [38,40,45,66].
Since mTORC1 was involved in the circadian phase-dependent
modulation of L-VGCCα1D trafficking and translocation
(Figures 4 and 5), we next investigated whether there was any
cross-talk between mTORC1 and MAPK-ERK or PI3K-AKT
signaling. As parallel pathways, inhibitors that block MAPK-
ERK signaling do not affect the circadian rhythm of pAKT and
vice versa. We found that treatment with rapamycin did not
affect the circadian rhythm of pAKTthr308 (Figure 6A) or pERK
(Figure 6F). Treatment with PP242 inhibited pAKTthr308 both at
night (CT 16) and during the day (CT 4; Figure 6A) but did not
affect pERK (Figure 6F). The effect of PP242 on pAKT might
be due to its non-specific inhibition of both mTORC1 and
mTORC2, since AKT is a known downstream target of
mTORC2 [14,67]. As a positive control, both rapamycin and
PP242 completely abolished the phosphorylation of S6 (pS6), a
direct downstream target of mTORC1 (Figure 6B). When
cultured retinas were treated with PD98059 (50 µM), a MEK1
inhibitor, the circadian rhythm of pAKTthr308 (Figure 6C [40]) and
pS6 (Figure 6D) were not affected, but the phosphorylation of
ERK (pERK) was completely inhibited since MEK1 is directly
upstream of ERK (Figure 6E). When cultured retinal cells were
treated with the PI3K inhibitor LY294002 (50 µM), the
phosphorylation of AKT thr308 (Figure 6C) and S6 (Figure 6D)
were completely abolished but did not affect the circadian
rhythm of pERK (Figure 6E [40]). Through these
pharmacological studies, we concluded that mTORC1 was
downstream of PI3K-AKT, but independent from MAPK-ERK
signaling, to regulate the circadian rhythm of L-VGCCs.
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Figure 2.  mTORC1 inhibitor dampens the circadian rhythm of L-VGCC currents.  L-VGCCs were recorded from cultured chick
cone photoreceptors on the sixth day of LD entrainment during the day (ZT 4-7) or at night (ZT 16-19). (A) Representative day (ZT
4-7) and night (ZT 16-19) control L-VGCC current traces from cells treated with 0.1% DMSO; (A) ramp command, (B) step
commands. (C) Two representative traces from cells that were treated with rapamycin (1 µM) for 2 hr prior to recordings. (D) and (E)
The average current-voltage (I–V) relationships are shown in current density (pA/pF) and step-voltage (mV). * indicates that the
control group at ZT 16-19 is significantly different from the other groups. (F) The maximal current densities were elicited at 0 mV. *
indicates that the L-VGCC current density recorded at night (control, ZT 16-19; n=23) is significantly higher than those recorded
during the day (control, ZT 4-7; n=21), rapamycin treated cells recorded during the day (ZT 4-7; 1 µM n=16; 10 µM n=13) and night
(ZT 16-19; 1 µM n=18; 10 µM n=13). * indicates that the L-VGCC current density recorded from the control cells at night (control,
ZT16-19) is significantly higher than all other groups. *p<0.05.
doi: 10.1371/journal.pone.0073315.g002
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Figure 3.  mTOR signaling regulates the circadian phase-dependent modulation of L-VGCCs.  (A) Representative L-VGCC
current traces from cells treated with 0.1% DMSO (control) or PP242 (100 nM or 400 nM) are shown. (B) The average current-
voltage (I–V) relationships from cells treated with 0.1% DMSO (control) or PP242 (100 nM) are shown in current density (pA/pF) and
step-voltage (mV). (C) The maximal current densities were elicited at 0 mV of the step command. * indicates that the L-VGCC
current density of the controls recorded at night (ZT 16-19) is significantly higher than control and PP242 (100 nM) treated cells
recorded during the day (ZT 4-7). PP242-treated cells that were recorded at night (ZT 16-19) have no statistical difference (n.s.) in
L-VGCC current densities when compared to PP242-treated cells recorded during the day (ZT 4-7) or the controls recorded at night
(ZT 16-19). Each group had at least 15 cells. (D) The average current-voltage (I–V) relationships from cells treated with 0.1%
DMSO (control) or PP242 (400 nM) are shown in current density (pA/pF) and step-voltage (mV). * indicates that the L-VGCC current
density of the controls recorded at night (ZT 16-19) is significantly higher than the other three groups. (E) Treatment with PP242 at
400 nM significantly dampened the circadian rhythm of maximal L-VGCC current densities. Each group had at least 15 cells. *
indicates that the L-VGCC current density of the control group at night (ZT 16-19) is significantly higher than the other three groups.
(F) Treatment with either rapamycin (10µM, 1µM) or PP242 (400nM) does not inhibit calcineurin activity compared to the control
(0.1% DMSO) cultures. n=6 for each group. *p<0.05.
doi: 10.1371/journal.pone.0073315.g003
mTORC1 and L-Type Voltage-Gated Calcium Channel
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Figure 4.  mTORC1 inhibition dampens the circadian rhythm of L-VGCCα1D.  Retinal cells were cultured on glass coverslips
and entrained to 12 hr LD cycles for four days in vitro and kept in DD. On the second day of DD, cells were treated with rapamycin
at CT 2 and CT 14 for 2 hr followed by fixation at CT 4 and CT 16. After washing and blocking, cells were processed for L-
VGCCα1D immunofluorescent staining. (A) Epifluorescent photos from the control (top panel) and rapamycin treated (lower panel)
groups. The photographs shown here were slightly over-exposed to provide clearer images but were not used for statistical analysis
in (B). The arrowheads indicate the cone photoreceptors. (B) The fluorescence intensity of L-VGCCα1D was significantly higher at
CT 16 (control) compared to all other groups. Each group has at least 15 cells from 4 different trials. *p<0.05.
doi: 10.1371/journal.pone.0073315.g004
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Figure 5.  Inhibition of mTORC1 causes a circadian phase-dependent decrease in the protein expression and plasma
membrane distribution of L-VGCCα1D.  Chick embryos (E11) were entrained in LD cycles for 7 days in ovo, and retinas were
dissected, cultured, and kept in DD. On the second day of DD, cultured retinal cells were treated with 0.1% DMSO (control),
rapamycin, or PP242 for 2 hr prior to harvest at CT 4 and CT 16. (A) In the whole cell lysate, the total protein expression of L-
VGCCα1D was significantly higher at night (CT 16) of the control compared to all other groups. Treatment with either rapamycin or
PP242 dampened the circadian rhythm of L-VGCCα1D protein levels (B1-B3). After treatment with DMSO (control) or rapamycin for
2 hr, the distribution of L-VGCCα1D on the plasma membrane or cytosol was analyzed using biotinylation assays (B1).
Representative blots of L-VGCCα1D from the cytosolic compartment (cytosol) and membrane-bound fraction (membrane). Total
ERK served as loading control (B2). In the membrane-bound fraction, the L-VGCCα1D was significantly higher in control cells
harvested at CT 16 compared to other groups (B3). In the cytosolic compartment (cytosol), there was no difference in the quantity of
L-VGCCα1D among all groups. *p<0.05.
doi: 10.1371/journal.pone.0073315.g005
mTORC1 and L-Type Voltage-Gated Calcium Channel
PLOS ONE | www.plosone.org 9 August 2013 | Volume 8 | Issue 8 | e73315
Figure 6.  The mTORC1 pathway is downstream of PI3K-AKT.  Chick embryos (E11) were entrained in LD cycles for 7 days in
ovo, and retinas were dissected, cultured, and kept in DD. On the second day of DD, cultured retinas were treated with 0.1% DMSO
(control) or various inhibitors for 2 hr prior to harvest for immunoblotting at CT 4 and CT 16. (A) The phosphorylation of AKT at
thr308 (pAKTthr308) was significantly higher in the control and rapamycin treated cells at CT 16 compared to other groups. “n.s.”
indicates that there is no statical difference between the two CT 16 groups. * indicates statistical differences. (B) The
phosphorylation of S6 (pS6), a downstream target of mTORC1, is significantly higher in the control at CT 16 (*) compared to all
other groups. The level of pS6 in the control at CT 4 (#) is significantly higher than groups treated with rapamycin or PP242. (C) The
levels of pAKTthr308 are significantly higher in the control at CT 16 (*) and PD98059 treated group at CT 16 (*) compared to all other
groups. The levels of pAKTthr308 are significantly lower in both groups (CT 4 and CT 16) treated with LY294002 (#). (D) The levels of
pS6 are significantly higher in the control at CT 16 (*) and PD98059 treated group at CT 16 (*) compared to all other groups. (E) The
level of di-phosphorylated ERK (pERK) is significantly higher in the control at CT 16 (*), and there is no statistical difference
between the control at CT 16 and LY294002 treated group at CT 16. The pERK levels in both PD98059 treated groups (CT 4 and
CT 16) are significantly lower (#) compared to all other groups. (F) Treatment with rapamycin or PP242 does not affect the circadian
rhythm of pERK, in which the pERK level is significantly higher at night (CT 16, *) compared to the day time level (CT 4). *, # p<0.05.
doi: 10.1371/journal.pone.0073315.g006
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Discussion
Through four independent lines of investigation
(electrophysiology, immunofluorescent staining, Western
blotting, and surface biotinylation assays), we uncovered a new
functional role for mTORC1, the circadian regulation of ion
channels in cone photoreceptors. Inhibition of mTORC1
caused a circadian phase-dependent decrease of L-VGCC
currents, as well as the distribution of L-VGCCα1D in the
plasma membrane. Our results suggest that mTORC1 in part
was involved in the channel trafficking and translocation from
the cytosol to the plasma membrane, membrane insertion,
and/or membrane retention of L-VGCCα1D. This conclusion
was based on our previous observation, as well as others, that
the PI3K-AKT pathway is involved in ion channel trafficking
[40,64,65]. Since mTORC1 is downstream of PI3K-AKT
(Figures 6 and 7), it is reasonable to conclude that in part,
mTORC1 is involved in the circadian regulation of L-VGCC
trafficking. Since we showed that L-VGCCs are more abundant
in the plasma membrane at night compared to the day [40]
(Figure 5B), mechanisms involved in the circadian regulation of
L-VGCC plasma membrane insertion, membrane retention
[68], or recycling are all possible actions of mTORC1, which
will require further investigation.
The phosphorylation state of mTORC1-dependent signaling,
but not its total protein expression, was also under circadian
control. mTORC1 can be activated by phosphorylation at
ser2448 [48,49], while ser2481 is an autophosphorylation site
in the regulatory domain [69]. We found that the
phosphorylation of mTORC1 at ser2448 (pTORC1ser2448), but
not ser2481 (pTORC1ser2481), displayed circadian rhythm with a
peak at CT 12, which indicated that the activity of mTORC1
was under circadian control, and the circadian regulation of
mTORC1 was phosphorylation-site specific. The activation of
p70S6 kinase (p70S6K) is pTORC1ser2448 dependent [10], which
further phosphorylates S6 to initiate other cellular processes
Figure 7.  A schematic model summarizes the complex cell signaling in the circadian regulation of L-VGCCs.  The circadian
clock in the photoreceptor regulates the mRNA levels and protein expression of the channel forming L-VGCCα1 subunits. The
circadian clock also regulates the activities / phosphorylation states of cell signaling molecules. In part, the complex cell signaling
involves the trafficking, translocation, plasma membrane insertion, and/or membrane retention of L-VGCCα1. This model is based
on our previous observations [37,38,40,45,66], as well as the current results.
doi: 10.1371/journal.pone.0073315.g007
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[70]. We showed that the phosphorylation of p70S6K
(pp70S6K) and S6 (pS6) in the retina also displayed circadian
oscillations in synch with pTORC1ser2448.
Since we previously characterized the circadian regulation of
L-VGCCs is in part through both MAPK-ERK and PI3K-AKT
signaling [38,40,45], we further deciphered whether there was
any cross-talk among mTORC1, MAPK-ERK, and PI3K-AKT
signaling. PI3K-AKT signaling activates mTORC1
phosphorylation, while mTORC2 is upstream of PI3K-AKT [71].
Even though MAPK-ERK signaling may also stimulate the
mTORC1 dependent pathway [72], we did not observe any
cross-talk between them in the retina. Through a series of
pharmacological studies, we found that mTORC1-dependent
signaling was downstream of PI3K-AKT and independent from
MAPK-ERK (Figure 7). Hence, mTORC1-dependent signaling
served as part of the circadian output pathway to regulate L-
VGCCs in the retina.
mTORC signaling participates in many cellular processes
including protein and lipid synthesis, metabolism, cell survival,
growth [71], and is an important regulator of ribosome
biogenesis [73]. When cellular energy levels are high, mTORC
signaling promotes energy expenditure in processes such as
protein translation and prevents autophagy [74]. When cells are
under stress or nutrient-deprived conditions, mTORC signaling
has the opposite action [75]. In the retina, activation of mTORC
delays retinal cell death and promotes axon regeneration
[16–20], but its inhibition results in the loss of cone
photoreceptor opsins and retinal degeneration [17]. Therefore,
mTORC promotes survival and neural protection. In addition,
mTORC1 signaling is known to be involved in the circadian
rhythms of both vertebrates and invertebrates [21–23]. The
mammalian master circadian clocks are located in the
suprachiasmatic nucleus (SCN) of the hypothalamus [76]. The
phosphorylation state of mTORC1-dependent signaling
displays circadian rhythms in the mouse SCN [47]. mTORC1
activity is light-inducible and involved in light-dependent
circadian phase-shifting [22,23]. Disruption of mTORC1
signaling alters the light-induced expression of Period gene, a
core component of the molecular clock, in the SCN [22]. In
Drosophila, activation of mTORC1 impacts the nuclear
accumulation of the circadian oscillator genes and lengthens
the period of circadian oscillations [21]. Hence, mTORC1 plays
an important role in regulating circadian rhythms.
In the present study, we discovered that mTORC1 signaling
was involved in the circadian regulation of L-VGCCs in part
through promoting L-VGCCα1D subunit translocation into the
plasma membrane at night, and the activation of mTORC1
signaling was also under circadian control. Retinal
photoreceptors are non-spiking neurons [39], and many of their
intracellular processes including calcium homeostasis are
highly compartmentalized [77]. In the dark, calcium influx
through L-VGCCs at the synaptic terminals allows for the
continuous release of neurotransmitters from the ribbon
synapses [78]. In response to various light intensities, the
phototransduction cascade and changes in local intracellular
calcium take place in the outer segment [79–81]. Hence,
calcium plays different roles in different localized compartments
of photoreceptors.
In mammalian and avian photoreceptors, L-VGCCα1D is
mainly distributed in the inner segment, soma, and synaptic
terminals [38,63,82,83], where calcium is involved in the
regulation of metabolism and neurotransmitter release [84].
While the circadian oscillators in photoreceptors regulate daily
changes in various cellular processes, from gene and protein
expressions [32–35,38] to light sensitivities [85], all of these
processes are energy dependent. In addition, there are
circadian regulations of both cGMP-gated cation channels
[37,66,86] and L-VGCCs [38,40,45], which might ultimately
regulate calcium homeostasis in photoreceptors. In
vertebrates, glucose metabolism is under circadian control [87],
and hence, the circulating plasma glucose that reaches the
retina for neuronal fuel might be oscillating daily. We postulate
that the circadian regulation of L-VGCCs through mTORC1
signaling might be essential to photoreceptor metabolism and
energy expenditure, since metabolism and gene expression
occur in the inner segment and the soma [84,88], where L-
VGCCα1D is also heavily distributed. The circadian oscillation
in mTORC1 activation and the circadian phase-dependent
increase of L-VGCCs in the plasma membrane of inner
segments and the soma would allow for local increases of
calcium influx, which would further enhance calcium-dependent
gene / protein expressions, potentially for subsequent needs in
intersegmental transport [89], outer segment renewal [31], and
energy requiring retinomotor movement [29,30,90]. Disruption
of mTORC1 activation and L-VGCC circadian rhythm could
further alter intracellular calcium homeostasis, which might lead
to photoreceptor pathophysiological conditions and
degeneration. In summary, we showed that the activation of
mTORC1-dependent signaling was under circadian control,
and the circadian rhythm of L-VGCCs in cone photoreceptors
was in part through the PI3K-AKT-mTORC1 pathway. More
specifically, mTORC1 participated in the circadian phase-
dependent modulation of L-VGCCα1D trafficking and
translocation. Hence, mTORC1 signaling is indispensable in
maintaining healthy physiological function in the retina.
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